AGILENT TECHNOLOGIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.7 USD | +0.22% |
|
-5.68% | -4.53% |
| Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
| Apr. 09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Financials (USD)
| Sales 2024 * | 6.78B | Sales 2025 * | 7.22B | Capitalization | 38.81B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.35B | Net income 2025 * | 1.51B | EV / Sales 2024 * | 5.83 x |
| Net Debt 2024 * | 678M | Net Debt 2025 * | 1.61B | EV / Sales 2025 * | 5.6 x |
| P/E ratio 2024 * |
28.9
x | P/E ratio 2025 * |
25.5
x | Employees | 17,700 |
| Yield 2024 * |
0.71% | Yield 2025 * |
0.77% | Free-Float | 99.72% |
More Fundamentals
* Assessed data
More news
Latest transcript on Agilent Technologies, Inc.
More recommendations
More press releases
More news
| 1 day | -1.57% | ||
| 1 week | -8.66% | ||
| Current month | -8.98% | ||
| 1 month | -9.34% | ||
| 3 months | +1.52% | ||
| 6 months | +21.94% | ||
| Current year | -4.74% |
1 week
128.34
143.25
1 month
128.34150.14
Current year
126.74151.58
1 year
96.80151.58
3 years
96.80179.57
5 years
61.13179.57
10 years
33.12179.57
| Managers | Title | Age | Since |
|---|---|---|---|
Michael McMullen
CEO | Chief Executive Officer | 62 | 83-12-31 |
| Chief Executive Officer | 52 | - | |
Robert McMahon
DFI | Director of Finance/CFO | 55 | 18-08-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Heidi Fields
BRD | Director/Board Member | 69 | 00-01-31 |
Boon Hwee Koh
CHM | Chairman | 73 | 03-05-20 |
Dow Wilson
BRD | Director/Board Member | 64 | 18-03-19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.29% | 2 M€ | -.--% | ||
| 2.57% | 2 M€ | -25.75% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 132.7 | +0.22% | 1 303 352 |
| 24-04-18 | 132.4 | -1.57% | 1,936,566 |
| 24-04-17 | 134.6 | -1.64% | 2,084,075 |
| 24-04-16 | 136.8 | -2.44% | 1,345,667 |
| 24-04-15 | 140.2 | -0.36% | 1,506,028 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotes
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products:
- electronic measurement instruments;
- bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products;
- measurement instruments for semiconductors.
Net sales break down by source of income between sales of products (73.9%) and services (26.1%).
Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).
Calendar
2024-05-20
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
132.4
USD
Average target price
150.1
USD
Spread / Average Target
+13.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.74% | 38.81B | |
| +2.02% | 207B | |
| +2.17% | 175B | |
| +10.45% | 132B | |
| +16.62% | 99.1B | |
| -2.70% | 60.89B | |
| +13.38% | 52.04B | |
| -6.33% | 45.48B | |
| +9.89% | 38.77B | |
| +3.25% | 26.09B |
- Stock Market
- Equities
- A Stock
